Figure 2From: An investigation into pharmaceutically relevant mutagenicity data and the influence on Ames predictive potentialMutagenic substructure distributions of Ames test data sets (non-aryl-amine). Comparison of Novartis Set C (orange bars) and the Hansen et al. set, Set D (red bars) by mutagenic substructure counts taken from Kazius et al.Back to article page